Met inhibitor Orpathys and EGFR inhibitor Tagrisso combo could reshape primary treatment strategy for locally advanced or ...
Executive changes this week include Entera Bio and Rhythm Pharmaceuticals appointing new CMOs, and Longevica Therapeutics ...
CorTec said it received a second breakthrough device designation for its investigational Brain Interchange device for use to ...
Kenvue challenge led National Advertising Division to question Hims & Hers’ use of “trust” as synonymous with “recommend” in ...
A Delaware federal court has entered a $245.2m judgment in favor of TwinStrand Biosciences in a patent infringement case ...
The firm has revealed the extent of the win seen in the ACACIA-HCM study in patients with symptomatic non-obstructive ...
The Rare Disease Endpoint Advancement and Model-Informed Drug Development programs eventually will drop participation limits ...
The decision comes as FDA employees face an already strained compensation environment and President Trump this week ...
Roivant’s Priovant subsidiary gained US approval of brepocitinib in dermatomyositis. Priovant is pursuing additional ...
A survey of 194 life sciences and medtech professionals showed that 63% expect AI investments to rise in 2027 with the ...
The FDA has selected Epitel's wearable EEG system and Prapela's infant cardiac device as the first participants in its ...
Indian firms lead Paragraph IV filings in the US as a wave of blockbuster drugs lose exclusivity between 2026-2028, but the ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results